Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Oct 20, 2009

Premium

Jay Therrien has been named vice president of global sales for next-generation sequencing at Life Technologies. Most recently, Therrien was director of sales for Asia Pacific and Japan for Illumina, which he joined in 2004 as a regional account manager. He holds a PhD from the University of Kansas and a bachelor's degree from the University of Illinois at Urbana-Champaign.


Evan Eichler has joined the scientific advisory board of Pacific Biosciences. He is a professor of genome sciences at the University of Washington School of Medicine. Eichler holds a PhD from the Department of Molecular and Human Genetics at Baylor College of Medicine and a BS in biology from the University of Saskatchewan.


Avak Kahvejian has been promoted from senior product manager to director of business development at Helicos BioSciences. He joined the company in 2004. Kahvejian holds BS and PhD degrees in biochemistry from McGill University.


Leroy Hood and David Galas are among the founders of Integrated Diagnostics, a company that will focus on developing personalized and preventive diagnostics based on organ-specific proteins.

Hood is the president of the Institute for Systems Biology in Seattle and an inventor of automated fluorescence-based DNA sequencing. Galas is a professor at ISB and vice president and CSO of the Battelle Memorial Institute. In the past, he was director for health and environmental research at the US Department of Energy's Office of Science, where he headed the DOE's Human Genome Project from 1990 to 1993.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more